Ashley Wofford Leong
Family Medicine · Cary, NCNPI 1437412871
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Novo Nordisk at 29.4% of the total. Reporting peaked in 2019 at $955 and has fallen 97.4% since, to $25 in 2025.
Across 103 payments — averaging $13.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$408
- Lilly USA, LLC$133
- Takeda Pharmaceuticals U.S.A., Inc.$120
- AbbVie$90
- Abbott$81
- Boehringer Ingelheim$80
- plus $476 from 17 others
What the payments were for
- Food & beverage$1,388100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 34 | $408 |
| Lilly USA, LLC | 12 | $133 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $120 |
| AbbVie(2 entities) | 6 | $90 |
| Abbott | 3 | $81 |
| Boehringer Ingelheim | 5 | $80 |
| Merck | 5 | $59 |
| AstraZeneca | 4 | $51 |
| Amgen | 3 | $46 |
| Amarin Pharma, Inc. | 3 | $40 |
| Astellas Pharma US Inc | 2 | $40 |
| Pfizer | 3 | $36 |
| Antares Pharma, Inc. | 2 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| GSK | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Bausch Health US, LLC | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Smith+Nephew | 1 | $12 |
| Gilead | 1 | $11 |
How this compares
$1,388 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Cary
- Christopher ChaoCary$201K
- Charlie FosterCary$23K
- Jing ZhangCary$23K
- David AdamsCary$20K
- William CromwellRaleigh$879K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.